[Neuropharmacological activity of 2 newly synthesized compounds from the piperazine group. I. The effect on experimental models of excitation and inhibition of the central nervous system].
D000578:Amidines / Q000494:pharmacology* / Q000633:toxicity; D000818:Animals; D002490:Central Nervous System / Q000187:drug effects*; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D006146:Guanidines / Q000494:pharmacology* / Q000633:toxicity; D007928:Lethal Dose 50; D051379:Mice; D008815:Mice, Inbred Strains; D009433:Neural Inhibition / Q000187:drug effects*; D010879:Piperazines / Q000494:pharmacology* / Q000633:toxicity; D051381:Rats; D011919:Rats, Inbred Strains
D000578:Amidines; D006146:Guanidines; D010879:Piperazines; C050210:1-benzyl-4-(guanidinoiminomethyl)piperazine; C058604:GP 4
Nevrofarmakologichna aktivnost na dve novosintezirani sŭedineniia ot grupata na piperazina. I sŭobshtenie. Vliianie vŭrkhu eksperimentalno predizvikani modeli na vŭzbuda i potiskane na tsentralna nervna sistema.